Alvotech to Participate in Morgan Stanley Annual Sustainable Finance Summit
May 17, 2023 05:00 ET
|
Alvotech
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Morgan...
Alvotech Issues Annual Equality Report Covering 2022
May 15, 2023 05:00 ET
|
Alvotech
Alvotech’s global workforce is now evenly split between females and males, and the unexplained gender pay gap has been reduced to 1.6% from 5.2% in December 2020Alvotech’s Equality Policy, which is...
Alvotech birtir skýrslu um þróun jafnréttismála á árinu 2022
May 15, 2023 05:00 ET
|
Alvotech
Hlutfall karla og kvenna í starfsliði Alvotech er nú jafnt og óútskýrður kynbundinn launamunur dróst saman úr 5,2% í desember 2020 í 1,6% í desember 2022Jafnréttisstefna Alvotech fylgir íslenskri...
Alvotech Issues Annual Equality Report Covering 2022
May 15, 2023 05:00 ET
|
Alvotech
Alvotech’s global workforce is now evenly split between females and males, and the unexplained gender pay gap has been reduced to 1.6% from 5.2% in December 2020Alvotech’s Equality Policy, which is...
Alvotech semur við Polifarma um markaðssetningu fyrirhugaðrar líftæknilyfjahliðstæðu við Eylea (aflibercept)
May 10, 2023 05:00 ET
|
Alvotech
Polifarma öðlast rétt til að markaðssetja AVT06, fyrirhugaða líftæknilyfjahliðstæðu við Eylea® (aflibercept) í Tyrklandi Alvotech (NASDAQ: ALVO) tilkynnti í dag um undirritun samnings við Polifarma...
Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)
May 10, 2023 05:00 ET
|
Alvotech
Polifarma will commercialize AVT06, a proposed biosimilar to Eylea® (aflibercept), in Turkey Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of...
Alvotech enters into commercialization agreement with Polifarma for proposed biosimilar to Eylea® (aflibercept)
May 10, 2023 05:00 ET
|
Alvotech
Polifarma will commercialize AVT06, a proposed biosimilar to Eylea® (aflibercept), in Turkey REYKJAVIK, Iceland, May 10, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company...
Aðalfundur Alvotech S.A. boðaður 6. júní 2023
May 05, 2023 09:00 ET
|
Alvotech
Aðalfundur Alvotech S.A. verður haldinn þriðjudaginn 6. júní 2023, kl. 09.00 CEST á skrifstofu Arendt & Medernach S.A að 41A Avenue John F. Kennedy, L-1855 Lúxemborg. Drög af dagskrá fundarins...
Alvotech S.A. Annual General Meeting to be held June 6, 2023
May 05, 2023 09:00 ET
|
Alvotech
The Annual General Meeting of Alvotech S.A. will be held on Tuesday 6 June 2023, at 09.00 a.m. CEST at the premises of Arendt & Medernach S.A. at 41A, Avenue John F. Kennedy L-1855 Luxembourg,...
Alvotech Initiates Confirmatory Patient Study for AVT05, a Proposed Biosimilar for Simponi® and Simponi Aria®
May 04, 2023 05:00 ET
|
Alvotech
The clinical study will compare AVT05 and Simponi® in patients with moderate to severe rheumatoid arthritis Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and...